These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14713961)

  • 1. p53 is a regulator of macrophage differentiation.
    Matas D; Milyavsky M; Shats I; Nissim L; Goldfinger N; Rotter V
    Cell Death Differ; 2004 Apr; 11(4):458-67. PubMed ID: 14713961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.
    Vesely DL; Hoffman B; Liebermann DA
    Oncogene; 2007 May; 26(21):3041-50. PubMed ID: 17099722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.
    Ronen D; Schwartz D; Teitz Y; Goldfinger N; Rotter V
    Cell Growth Differ; 1996 Jan; 7(1):21-30. PubMed ID: 8788030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells.
    Peled A; Schwartz D; Elkind NB; Wolkowicz R; Li R; Rotter V
    Oncogene; 1996 Oct; 13(8):1677-85. PubMed ID: 8895513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels.
    Zhang J; Yan W; Chen X
    Cell Death Differ; 2006 Dec; 13(12):2118-28. PubMed ID: 16729028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
    Shaulsky G; Goldfinger N; Rotter V
    Cancer Res; 1991 Oct; 51(19):5232-7. PubMed ID: 1717142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ES cell differentiation by functional and conformational modulation of p53.
    Sabapathy K; Klemm M; Jaenisch R; Wagner EF
    EMBO J; 1997 Oct; 16(20):6217-29. PubMed ID: 9321401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells.
    Blandino G; Scardigli R; Rizzo MG; Crescenzi M; Soddu S; Sacchi A
    Oncogene; 1995 Feb; 10(4):731-7. PubMed ID: 7862450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
    Li J; Zhang X; Sejas DP; Pang Q
    Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis.
    Sigal A; Matas D; Almog N; Goldfinger N; Rotter V
    Oncogene; 2001 Aug; 20(35):4891-8. PubMed ID: 11521201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis.
    Lee MK; Hande MP; Sabapathy K
    J Cell Sci; 2005 Feb; 118(Pt 4):819-29. PubMed ID: 15687103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.
    Banerjee D; Lenz HJ; Schnieders B; Manno DJ; Ju JF; Spears CP; Hochhauser D; Danenberg K; Danenberg P; Bertino JR
    Cell Growth Differ; 1995 Nov; 6(11):1405-13. PubMed ID: 8562479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment and characterization of rat myelomonocytic leukemia clones undergoing differentiation or apoptosis].
    Yoshida H
    Hokkaido Igaku Zasshi; 2000 Nov; 75(6):375-84. PubMed ID: 11193930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.